ライフサイエンスコーパス: deferral

1 or more of intensive treatment or treatment deferral).

2 tely after 3 weeks of treatment or treatment deferral.

3 2), but not from baseline to after treatment deferral (-0.03 points [4.04]; -0.94 to 0.88; between-gr

4 ation rates include increased rates of donor deferral and ineligibility; increased barriers to donati

5 c health measures that rely largely on donor deferral and sourcing of blood from non-outbreak areas u

6 resulted in more donation-related symptoms, deferrals, and iron deficiency.

7 haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin.

8 allocated immediate CEA versus all allocated deferral, but excluding such perioperative events, the 5

9 Source selection (e.g. country of origin, deferral for CJD risk factors) currently occupies the fr

10 globin and ferritin concentrations, and more deferrals for low haemoglobin (p<0.0001 for each) than t

11 interval, 0.4-5.4 letters; P = 0.02) in the deferral group compared with the prompt laser treatment

12 In the deferral group, 54% did not receive laser treatment duri

13 In the prompt laser treatment group and deferral group, respectively, the percentage of eyes wit

14 njections was 13 versus 17 in the prompt and deferral groups, including 54% and 45% receiving no inje

15 injections were 12 and 15 in the prompt and deferral groups, respectively (P = 0.007), including 1 a

16 For the deferral groups, the index visit was a randomly selected

17 erapy strategies, postoperative radiotherapy deferral has gained acceptance in children younger than

18 th poorer OS were postoperative radiotherapy deferral (hazards ratio [HR], 1.95; 95% CI, 1.15-3.31);

19 ncreasing rate of postoperative radiotherapy deferral in children with medulloblastoma ages 3 to 8 ye

20 sis suggests that postoperative radiotherapy deferral is associated with worse survival in this age g

21 Thus, deferral is controlled by a pulsed positive feedback loo

22 ily values regarding nondisclosure, but such deferral is not unique to cultural differences.

23 by angiography, including revascularization deferral, is safe in ACS.

24 delay 1 month, IQR 0.3-2.5) or to indefinite deferral of any carotid procedure, and were followed up

25 llocated immediate CEA versus 1560 allocated deferral of any carotid procedure.

26 EA by 1 month, 88% by 1 year) and indefinite deferral of any CEA (only 4% per year got CEA) and were

27 ous Medicaid enrollment, continuity of care, deferral of care, and number of visits.

28 he availability of the perfusion data led to deferral of catheterization in 48 cases (46.6%).

29 Stenting allowed deferral of complete surgical repair to an age (6 months

30 m baseline to follow-up examination, despite deferral of coronary intervention in all patients.

31 The deferral of events in mammalian embryogenesis might be d

32 w risk of decompensations in the short term; deferral of HCV therapy for a few years and monitoring f

33 nguage therapy (>/=10 h per week) or 3 weeks deferral of intensive speech and language therapy.

34 This study is clinically relevant because deferral of on time implantation leads to spontaneous pr

35 trated that the use of upfront EGFR-TKI, and deferral of radiotherapy, is associated with inferior OS

36 ographically indeterminate LMCA lesions, and deferral of revascularization was recommended when the M

37 g the sporulation kinases, without which the deferral of sporulation became ultrasensitive to kinase

38 Episodic use involved the deferral of therapy until the CD4+ count decreased to le

39 ned by whether the patient will be harmed by deferral of therapy.

40 At the lesion level, deferral of those with an FFR</=0.80 was associated with

41 isits, greater continuity of care, and fewer deferrals of care.

42 d adverse events during therapy or treatment deferral (one car accident [in the control group], two c

43 abine (200 mg) either immediately or after a deferral period of 1 year.

44 s included incident HIV infection during the deferral period, safety, adherence, and risk compensatio

45 interventions since 1970, particularly donor deferral, screening for hepatitis B and human immunodefi

46 How can cells set a deferral time much longer than the cell cycle?

47 provides a more robust mechanism for setting deferral times than constitutive kinase expression.

48 back can enable more accurate tuning of long deferral times.

49 re 2.68 (p = 0.003) and 1.05 (p = 0.897) for deferral to <200 cells/microl and 200-349 cells/ micro l

50 on between July 1995 and January 2000: <200 (deferral to <200, n = 127), 200-349 (deferral to 200-349

51 : <200 (deferral to <200, n = 127), 200-349 (deferral to 200-349, n = 130), and 350-499 (immediate tr

52 Moreover, FFR-based deferral to medical treatment was as safe in patients wi

53 0 cells per muL assigned to immediate ART or deferral until their CD4 cell counts were lower than 350

54 s associated with postoperative radiotherapy deferral were age (odds ratio [OR], 0.57 per year; 95% C

55 s associated with postoperative radiotherapy deferral were identified using multivariable logistic re

56 mpliance with allocation to immediate CEA or deferral would, in expectation, have produced slightly b